For Industry
April 18, 2012
AGDUFA II Negotiations
Center for Veterinary Medicine (CVM)
Metro Park North, Rockville, MD 20855
April 18, 2012
9:00 am – 10:30 am
Purpose
To review the proposed changes made to the draft statutory language and performance goals letter for AGDUFA II
Participants
FDA Industry Steve Vaughn, CVM Stephanie Batliner, GADA David Wardrop, CVM Jennifer Johansson, GADA Roxanne Schweitzer, CVM Colin Gray, GADA Ken Harshman, CVM Gerald Macedo, GADA Julie Bailey, CVM Herschel Gaddy, GADA Petra Garosi, CVM James Viseio, GADA Yanming Chae, CVM Jason Chen, GADA Frank Claunts, Consultant Ted Sullivan, GADA
FDA and Industry reviewed and made edits to the final draft of proposed statutory changes, which reflected AGDUFA II fee revenues and agreements on inflation and workload adjusters.
FDA and Industry reviewed and made edits to the final draft of the AGDUFA II performance goals letter which reflected AGDUFA II agreements on enhancements for the review process.
FDA informed Industry about the next steps moving forward. No future meeting was set at this point. Neither FDA nor Industry Ratifiers have approved the tentative agreements mentioned above at this time.
There were no other substantive proposals, significant controversies, or differences of opinion discussed at this meeting.







